Today: 8 June 2026
Hindustan Zinc share price today: HINDZINC stock stays near 52-week high as record silver fuels fresh bull case
23 December 2025
6 mins read

Hindustan Zinc share price today: HINDZINC stock stays near 52-week high as record silver fuels fresh bull case

Hindustan Zinc Limited (NSE: HINDZINC, BSE: 500188) was back in the spotlight on December 23, 2025, with the stock trading in the ₹606–₹615 zone and hovering near fresh 52-week highs after a sharp metals-led run-up this month.

The timing isn’t random. Global precious metals have been on a tear: silver hit a new all-time high near $70/oz while gold pushed to record territory, turbocharging sentiment for companies with meaningful silver exposure—especially Hindustan Zinc, one of India’s most leveraged listed plays on silver prices.

At the same time, broker commentary has turned louder. A bullish initiation from Jefferies with a ₹660 target has become the headline “north star” for momentum traders, even as broader analyst consensus remains more cautious on valuation after the rally. India Today+1

What’s driving Hindustan Zinc stock on Dec 23, 2025

Three forces are doing the heavy lifting:

1) Record silver (and gold) is lifting the entire “precious metals beta” complex
Reuters reported spot silver touched a record $69.98/oz and remained near $69.44/oz early Tuesday, with year-to-date gains topping 141%—outpacing gold. Reuters

That matters because Hindustan Zinc’s earnings mix has steadily shifted: silver is no longer “just a by-product story”—it’s a profit engine.

2) Investors are treating HZL as a clean listed proxy for silver upside
Jefferies explicitly frames Hindustan Zinc as an “attractive way to play” the global silver rally, arguing that even conservative long-range silver price assumptions still leave room for strong cash generation and returns. India Today

3) Metals momentum is broad-based, not a one-stock island
Indian equities were broadly flat in holiday-thinned trading, but sector rotations have kept metals on the bid—helpful context for why dips are being bought quickly in metal-heavy counters.

The silver angle: why it’s not just a price spike story

Hindustan Zinc is India’s top refined zinc producer and a major silver producer; Reuters has described it as the world’s third-largest silver producer and notes India is the world’s biggest silver consumer—both supporting the narrative that domestic and industrial demand can reinforce global pricing cycles.

Jefferies goes further, arguing the company deserves a valuation premium because silver is becoming structurally more important to profitability. In its initiation note, Jefferies says silver contributes about 40% of EBIT, and expects silver’s role in the profit mix to grow further over coming years.

That thesis is echoed in the company’s own commentary: in its FY26 investor communication, Hindustan Zinc highlights that silver drives ~40% of overall profit, underscoring why the market reacts so aggressively to every leg up in silver.

Latest performance snapshot: strong margins and cost discipline

The most recent detailed operating and financial disclosures (FY26 investor materials and Q2 coverage) point to two big investor takeaways: high operating leverage and tight costs.

From Hindustan Zinc’s Q2 FY26 highlights, the company reported (among other metrics):

  • Revenue: ₹8,549 crore
  • EBITDA: ₹4,467 crore
  • Profit after tax: ₹2,649 crore
  • EBITDA margin: 52%
  • Mined metal production: 258 kt (highlighted as best-ever second-quarter mined metal)
  • Zinc cost of production: $994/MT

Reuters’ coverage of the same quarter adds macro color: consolidated net profit rose nearly 14% year-on-year to ₹26.49 billion (₹2,649 crore) and revenue from operations increased to ₹85.49 billion, helped by higher silver prices and steady zinc demand.

The strategic point investors keep circling: when silver rises sharply, Hindustan Zinc’s earnings don’t just “improve”—they can snap upward because much of the operating base is already in place.

Hindustan Zinc forecasts: what guidance and broker models imply

Company guidance for FY26 (production, costs, capex)

In its FY26 outlook, Hindustan Zinc guided to:

  • Mined metal: 1,125 (±10) kt
  • Refined metal: 1,100 (±10) kt
  • Saleable silver: 700–710 MT
  • Zinc cost of production: $1,025–$1,050/MT
  • Growth capex: $225–$250 million

That guidance is the “base case” investors are using to sanity-check whether the current rally is purely price-driven—or also supported by volume/cost improvements.

Jefferies forecast and target price: ₹660 bull case (with conservative commodity assumptions)

Jefferies initiated coverage with a Buy and a ₹660 target, saying the target implies roughly 22% upside including ~4% dividend yield (based on its assumptions at the time).

Key Jefferies projections include:

  • EPS growth: 22% (FY26), 29% (FY27), and 7% (FY28)
  • Estimates described as 9% to 31% higher than consensus forecasts
  • FY27 EV/EBITDA: 9.2x (vs ~7.3x 10-year average cited)
  • Assumed long-range prices (H2 FY26–FY28): zinc $3,225–$3,250/tonne, silver $56–$60/oz (below spot at the time)
  • Forecast annual free cash flow range: ₹8,000–₹14,800 crore

A fun market irony here: Reuters reported spot silver near $69.44/oz on Dec 23, while Jefferies’ modeled silver range is materially lower—so the bull case is explicitly not assuming “spot stays euphoric forever.” Reuters+1

Consensus is cooler: “Hold” bias and lower median target

Not everyone is chasing the breakout at current levels.

A Reuters/Refinitiv snapshot (via LSEG compiled data) noted:

  • Average rating: “Hold” (14 analysts)
  • Median price target: ₹491.50
  • Stock up ~36% YTD at the time of that note

This gap between the Jefferies target and the median target is essentially the market’s debate in one line: is Hindustan Zinc now a “silver-growth compounder,” or still primarily a cyclical with a valuation ceiling?

Expansion and capex: the growth story that could outlast a commodities cycle

Hindustan Zinc isn’t standing still operationally—several projects and approvals are aimed at extending mine life, lifting recoveries, and expanding capacity.

  • New metals complex in Rajasthan: Reuters reported the company approved an expansion project worth ₹120 billion to establish a new metals complex with 250 KT capacity, expected within 36 months, as it aims to double output over time.
  • Zinc tailings reprocessing: The company has also highlighted approval for a 10 MTPA zinc tailings reprocessing plant—a project type investors often like because it can improve resource efficiency and support ESG narratives (though execution and economics still matter).

If these projects deliver on time and within budget, they help justify the argument that Hindustan Zinc’s value is not only “metal price × current capacity,” but also a pipeline of incremental throughput and recovery gains.

Ownership, government stake, and the “Vedanta factor” investors can’t ignore

Hindustan Zinc’s shareholding structure is unusually important for stock-watchers because it can affect supply, sentiment, and headline risk.

As per the company’s shareholding filing for the quarter ended September 30, 2025:

  • Vedanta Limited holds 61.84%
  • President of India account holds 27.92%

Two implications follow:

1) Promoter actions can move the stock
A prior report noted Vedanta planned to sell about 1.6% in Hindustan Zinc via block deals to raise roughly ₹3,018 crore (headline risk for price discovery when supply hits).

2) Promoter encumbrance is a real risk variable
The same shareholding disclosure indicates promoter shares are pledged/otherwise encumbered at significant levels (a datapoint also flagged by market screeners). High encumbrance doesn’t automatically mean distress, but markets tend to assign it a risk premium because it can amplify volatility during promoter funding events.

Separately, the Vedanta ecosystem itself is in motion: Reuters reported India’s tribunal cleared Vedanta’s demerger plan, targeting completion by March 31, 2026. That’s not directly “a Hindustan Zinc event,” but it can influence sentiment around promoter leverage and strategic optionality. Reuters

Technical view: momentum is strong, but “buy-the-dip” is replacing “buy-anything”

Technicians have been highlighting Hindustan Zinc’s breakout behavior after a multi-month consolidation, with short-term targets being discussed above ₹600 and a preference to accumulate on pullbacks rather than chase vertical candles.

This matches the feel of the tape on Dec 23: the stock isn’t exploding every hour, but it’s holding gains close to highs—often what strong trends do before they either continue… or finally run out of oxygen.

Key risks investors are weighing right now

Even with the silver narrative firing on all cylinders, this is still a mining-and-metals stock, meaning risk comes bundled with the opportunity:

  • Commodity risk: Silver and zinc can fall hard and fast; even Reuters flagged thinner year-end liquidity potentially amplifying price swings.
  • Valuation risk: Jefferies itself acknowledges a premium valuation versus historical averages, arguing it’s justified by silver mix—others disagree, and consensus targets reflect that split.
  • Execution risk: Expansions (new complex, reprocessing plants) create upside, but delays and cost overruns can dent the story.
  • Promoter/ownership overhang: Pledges/encumbrances and potential stake sales can pressure sentiment regardless of operating performance.

What to watch next after Dec 23

For the next few weeks, Hindustan Zinc investors are likely tracking five “live wires”:

  1. Silver price direction after hitting records (does it consolidate, or trend higher again?)
  2. Management commentary on costs and FY26 delivery vs guidance
  3. Update cadence on big capex projects (timelines, funding mix, returns)
  4. Promoter headlines (stake sale chatter, encumbrance changes, group restructuring developments)
  5. The Q3 earnings runway—even Reuters noted markets are looking toward the upcoming earnings season for confirmation of profit momentum.

Bottom line

As of December 23, 2025, Hindustan Zinc stock is behaving like a textbook “macro + fundamentals” momentum name: record silver prices are powering sentiment, recent margins and cost performance support the narrative, and Jefferies has put a prominent ₹660 marker on the upside debate. Reuters+2Hindustan Zinc+2

But the market isn’t unanimous. LSEG-compiled consensus still skews Hold with a much lower median target—signaling that at least part of the street believes a lot of good news is already in the price.

In other words: Hindustan Zinc is currently a battleground between “silver is structural” and “cycles always humble optimism.” The next act will be written by the metal prices, execution on capacity/cost, and how cleanly the ownership overhang stays out of the way.

Stock Market Today

  • Tech Stocks Slide on Broadcom Decline and Strong Jobs Report, Momentum Stocks Weaken
    June 8, 2026, 11:24 AM EDT. Tech stocks fell sharply as Broadcom dropped 13% following solid but uninspiring earnings, dragging memory stocks lower. A blowout U.S. jobs report sent Treasury yields higher, reducing expectations for rate cuts and pressuring riskier assets, including momentum-driven tech shares like Micron and Marvell Technology. The S&P 500 fell 1.05% and the Nasdaq lost over 2.2%, risking the S&P's bid for a 10th consecutive weekly gain. Momentum stocks, the top-performing equity factor in 2026, struggled, while low volatility stocks saw some relief. Broad market weakness reflects a mix of profit-taking and macroeconomic concerns after a strong run in tech sector equities.

Latest articles

Alphabet’s $80 billion AI stock sale puts Google’s rally to the test

Alphabet AI Search Drives Wall Street Target Hikes, Cloud Margins Still Draw Scrutiny

8 June 2026
Alphabet has ordered over 3 million TPUs from Intel for 2028 as it ramps up AI infrastructure, prompting Piper Sandler to raise its price target to $445 on rapid AI-assisted search growth, while UBS warns faster Google Cloud TPU revenue could pressure margins; Alphabet shares recently traded at $362.21, down $6.32, after boosting its equity offering to $84.75 billion to finance the AI buildout.
$95 Billion Dividend ETF May Not Be As Safe As It Looks

$95 Billion Dividend ETF May Not Be As Safe As It Looks

8 June 2026
SCHD’s top 10 holdings now make up about 43.5% of assets, raising concentration risk just as investors pile in for safety after a tech-led selloff; with $95.17 billion in assets, a 3.24% yield, and a 0.06% expense ratio, SCHD traded up 0.4% to $32.44 Monday, but its performance and risk profile now hinge more than ever on a handful of big stocks.
Wall Street’s Chip Rebound Lifts Nasdaq — Inflation Test Comes Next

Wall Street’s Chip Rebound Lifts Nasdaq — Inflation Test Comes Next

8 June 2026
Intel soared 8.5% to lead a 4.6% surge in chip stocks after reports Alphabet tapped it to make 3 million in-house chips and Nvidia was evaluating its technology, powering a 1.43% Nasdaq jump as investors returned to AI trades ahead of Wednesday’s key inflation data; Citigroup raised its S&P 500 target to 8,100, but Goldman Sachs warned the Fed may keep rates unchanged through 2026.
Oil Pops, Tech Moves Sideways as Iran-Israel Tensions Flare

Oil Pops, Tech Moves Sideways as Iran-Israel Tensions Flare

8 June 2026
Wall Street’s main indexes rebounded at Monday’s open as chip stocks recovered and easing Middle East tensions offset an early oil price jump; the Dow rose 0.26%, S&P 500 gained 0.77%, and Nasdaq advanced 1.38%, after Friday’s tech rout and amid concerns the Fed may keep policy tighter for longer following strong U.S. jobs data.
Wall Street Hit With New AI Bubble Jitters as Doubts Grow

Wall Street Hit With New AI Bubble Jitters as Doubts Grow

8 June 2026
U.S. stocks rebounded Monday after a $2 trillion wipeout led by chip stocks, but investors are questioning whether massive AI spending can deliver durable earnings as strong jobs data dims hopes for Fed rate cuts, raising pressure on high-priced growth shares.
FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown
Previous Story

FDA Approves Wegovy Pill: Novo Nordisk’s Oral Semaglutide Launch Ignites a 2026 Weight‑Loss Drug Showdown

Eli Lilly Stock (LLY) Outlook on Dec. 23, 2025: Novo’s Wegovy Pill, Lilly’s Next Catalysts, and Wall Street Forecasts
Next Story

Eli Lilly Stock (LLY) Outlook on Dec. 23, 2025: Novo’s Wegovy Pill, Lilly’s Next Catalysts, and Wall Street Forecasts

Go toTop